Published in J Cardiovasc Pharmacol on June 01, 1988
Protection of atrial natriuretic factor against degradation: diuretic and natriuretic responses after in vivo inhibition of enkephalinase (EC 3.4.24.11) by acetorphan. Proc Natl Acad Sci U S A (1989) 0.94
Dissociation of natriuresis and diuresis and heterogeneity of the effector system of atrial natriuretic factor in rats. J Clin Invest (1989) 0.78
Adverse events associated with prescription drug cost-sharing among poor and elderly persons. JAMA (2001) 8.72
Mutations in ABC1 in Tangier disease and familial high-density lipoprotein deficiency. Nat Genet (1999) 7.30
Report of the Canadian Hypertension Society Consensus Conference: 1. Introduction. CMAJ (1993) 6.20
Awareness, treatment, and control of hypertension in Canada. Am J Hypertens (1997) 4.76
Homocyst(e)ine and cardiovascular disease: a critical review of the epidemiologic evidence. Ann Intern Med (1999) 3.63
Signal transduction mechanisms mediating the physiological and pathophysiological actions of angiotensin II in vascular smooth muscle cells. Pharmacol Rev (2000) 3.40
Recommendations from the Consensus Conference on Hypertension in the Elderly. CMAJ (1986) 3.06
Vascular remodeling in hypertension: roles of apoptosis, inflammation, and fibrosis. Hypertension (2001) 3.04
Prevalence, control and awareness of high blood pressure among Canadian adults. Canadian Heart Health Surveys Research Group. CMAJ (1992) 2.98
Distribution of blood pressure and hypertension in Canada and the United States. Am J Hypertens (2001) 2.96
Reactive oxygen species in vascular biology: implications in hypertension. Histochem Cell Biol (2004) 2.46
Association of HbA1c levels with vascular complications and death in patients with type 2 diabetes: evidence of glycaemic thresholds. Diabetologia (2011) 2.28
Socio-economic disparities in preterm birth: causal pathways and mechanisms. Paediatr Perinat Epidemiol (2001) 2.19
c-Src induces phosphorylation and translocation of p47phox: role in superoxide generation by angiotensin II in human vascular smooth muscle cells. Arterioscler Thromb Vasc Biol (2003) 2.16
Pseudopheochromocytoma. Hypertension (1985) 2.15
Interindividual and interspecies variation in the metabolism of the hallucinogen 4-methoxyamphetamine. Xenobiotica (1979) 2.07
The 1993 guidelines for the management of mild hypertension: memorandum from a WHO/ISH meeting. Blood Press (1993) 2.03
Mutations in the ABC1 gene in familial HDL deficiency with defective cholesterol efflux. Lancet (1999) 2.02
Vascular remodeling. Hypertension (1996) 1.99
The heart and the atrial natriuretic factor. Endocr Rev (1985) 1.99
Age and residual cholesterol efflux affect HDL cholesterol levels and coronary artery disease in ABCA1 heterozygotes. J Clin Invest (2000) 1.98
Rationale for and outline of the recommendations of the Working Group on Hypercholesterolemia and Other Dyslipidemias: interim report. Dyslipidemia Working Group of Health Canada. Can J Cardiol (1998) 1.88
RAS blockade decreases blood pressure and proteinuria in transgenic mice overexpressing rat angiotensinogen gene in the kidney. Kidney Int (2006) 1.88
Report of the Canadian Hypertension Society Consensus Conference: 5. Hypertension and diabetes. CMAJ (1993) 1.86
THE EFFECTS OF INTRAVENOUS INFUSIONS OF VALINE-5 ANGIOTENSIN II AND OTHER PRESSOR AGENTS ON URINARY ELECTROLYTES AND CORTICOSTEROIDS, INCLUDING ALDOSTERONE. J Clin Invest (1961) 1.84
Common genetic variation in ABCA1 is associated with altered lipoprotein levels and a modified risk for coronary artery disease. Circulation (2001) 1.71
Homocysteine and cardiovascular disease in diabetes mellitus. Atherosclerosis (2001) 1.69
Vascular calcifications in homozygote familial hypercholesterolemia. Arterioscler Thromb Vasc Biol (2008) 1.67
Plasma total homocysteine in healthy subjects: sex-specific relation with biological traits. Am J Clin Nutr (1996) 1.67
Apoptosis in pressure overload-induced heart hypertrophy in the rat. J Clin Invest (1996) 1.65
Structure and mechanical properties of resistance arteries in hypertension: role of adhesion molecules and extracellular matrix determinants. Hypertension (2000) 1.63
Early experience with laparoscopic approach for adrenalectomy. Surgery (1993) 1.61
Effect of native and synthetic atrial natriuretic factor on cyclic GMP. Biochem Biophys Res Commun (1984) 1.59
Angiotensin-forming enzyme in brain tissue. Science (1971) 1.55
Estimation of the state of the bacterial cell wall by fluorescent In situ hybridization. Appl Environ Microbiol (1998) 1.54
Antioxidant effects of vitamins C and E are associated with altered activation of vascular NADPH oxidase and superoxide dismutase in stroke-prone SHR. Hypertension (2001) 1.50
Percutaneous transluminal angioplasty in coronary-internal thoracic-subclavian steal syndrome. Can J Cardiol (1997) 1.46
Severe bronchospasm followed by respiratory arrest during thallium-dipyridamole imaging. Chest (1989) 1.45
Gastric inhibitory polypeptide-dependent cortisol hypersecretion--a new cause of Cushing's syndrome. N Engl J Med (1992) 1.45
The 2000 Canadian recommendations for the management of hypertension: Part one--therapy. Can J Cardiol (2001) 1.42
Differential effects of vasopressin and endothelin-1 on vascular contractile and calcium responses in pressurized small arteries from spontaneously hypertensive rats. J Hypertens (1996) 1.41
Lipoprotein (a) blood levels in unstable angina pectoris, acute myocardial infarction, and after thrombolytic therapy. Am J Cardiol (1991) 1.41
Localization of immunoreactive synthetic atrial natriuretic factor (ANF) in the heart of various animal species. J Histochem Cytochem (1985) 1.41
Vascular structure in NG-nitro-L-arginine methyl ester-induced hypertension: methodological considerations for studies of small arteries in hypertension. J Hypertens (1995) 1.39
Defective 3,4-dihydroxyphenylalanine decarboxylation to dopamine in hydralazine-treated hypertensive patients may be pyridoxine remediable. Am J Hypertens (1993) 1.38
Has the CMA become "big business"? CMAJ (1990) 1.37
Effects of a beta-blocker or a converting enzyme inhibitor on resistance arteries in essential hypertension. Hypertension (1994) 1.36
The increase of cGMP by atrial natriuretic factor correlates with the distribution of particulate guanylate cyclase. FEBS Lett (1985) 1.36
Production of insulin resistance by hyperinsulinaemia in man. Diabetologia (1985) 1.36
Twisting integrin receptors increases endothelin-1 gene expression in endothelial cells. Am J Physiol Cell Physiol (2001) 1.34
Influence of environmental temperature on the blood pressure of hypertensive patients in Montréal. Am J Hypertens (1991) 1.34
Measurement of renin in both renal veins. Its use in diagnosis of renovascular hypertension. Arch Intern Med (1967) 1.33
Resistance artery mechanics, structure, and extracellular components in spontaneously hypertensive rats : effects of angiotensin receptor antagonism and converting enzyme inhibition. Circulation (1999) 1.31
Arterial pressure, left ventricular mass, and aldosterone in essential hypertension. Hypertension (2001) 1.30
Ectopic and abnormal hormone receptors in adrenal Cushing's syndrome. Endocr Rev (2001) 1.30
Amino acid sequence of homologous rat atrial peptides: natriuretic activity of native and synthetic forms. Proc Natl Acad Sci U S A (1984) 1.28
Ang II-stimulated superoxide production is mediated via phospholipase D in human vascular smooth muscle cells. Hypertension (1999) 1.28
Aldosterone and angiotensin II synergistically stimulate migration in vascular smooth muscle cells through c-Src-regulated redox-sensitive RhoA pathways. Arterioscler Thromb Vasc Biol (2008) 1.28
Radioautographic localization of 125I-atrial natriuretic factor (ANF) in rat tissues. Histochemistry (1985) 1.26
Atrial natriuretic factor is a circulating hormone. Biochem Biophys Res Commun (1984) 1.26
Renin-aldosterone system in Parkinson's disease. Science (1969) 1.26
p47phox associates with the cytoskeleton through cortactin in human vascular smooth muscle cells: role in NAD(P)H oxidase regulation by angiotensin II. Arterioscler Thromb Vasc Biol (2004) 1.26
Patterns of compliance with once versus twice daily antihypertensive drug therapy in primary care: a randomized clinical trial using electronic monitoring. Can J Cardiol (1997) 1.26
The angiotensin II type 1 receptor and receptor-associated proteins. Cell Res (2001) 1.24
Ring-deleted analogs of atrial natriuretic factor inhibit adenylate cyclase/cAMP system. Possible coupling of clearance atrial natriuretic factor receptors to adenylate cyclase/cAMP signal transduction system. J Biol Chem (1990) 1.22
Specific receptor-mediated inhibition by synthetic atrial natriuretic factor of hormone-stimulated steroidogenesis in cultured bovine adrenal cells. Endocrinology (1984) 1.22
Molecular diversity and relationship within Lactococcus lactis, as revealed by randomly amplified polymorphic DNA (RAPD). Syst Appl Microbiol (1998) 1.22
Phenylpropanolamine, stroke and hypertension. CMAJ (2001) 1.21
Increased generation of superoxide by angiotensin II in smooth muscle cells from resistance arteries of hypertensive patients: role of phospholipase D-dependent NAD(P)H oxidase-sensitive pathways. J Hypertens (2001) 1.20
The atrial natriuretic factor: its physiology and biochemistry. Rev Physiol Biochem Pharmacol (1988) 1.20
Effects of individual risk factors on the incidence of cardiovascular events in the treated hypertensive patients of the Hypertension Optimal Treatment Study. HOT Study Group. J Hypertens (2001) 1.19
Role of the adrenal cortex and sodium in the pathogenesis of human hypertension. Can Med Assoc J (1978) 1.19
Immunocytochemical localization of atrial natriuretic factor in the heart and salivary glands. Histochemistry (1984) 1.19
Acute changes in plasma volume, renin activity, and free aldosterone levels in healthy subjects following Fursemide administration. Can J Physiol Pharmacol (1968) 1.18
Mechanics and composition of human subcutaneous resistance arteries in essential hypertension. Hypertension (1999) 1.17
Hypertension: genes and environment. J Hypertens (1998) 1.17
Diurnal variation of plasma vasopressin in man. J Clin Endocrinol Metab (1975) 1.16